Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients

U. Nowicka, E. Wiatr, J. Grudny, I. Bestry, P. Boros, B. Roszkowska (Warsaw, Poland)

Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Session: Clinical issues in diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 830
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Nowicka, E. Wiatr, J. Grudny, I. Bestry, P. Boros, B. Roszkowska (Warsaw, Poland). Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients. Eur Respir J 2010; 36: Suppl. 54, 830

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Small airways impairment and air-trapping in patients with chronic hypersensitivity pneumonitis (CHP) of different severity
Source: International Congress 2017 – Novel and old entities
Year: 2017

Relation between pulmonary function tests (PFTs) and severe asthma difficult to control
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Pulmonary disease in primary Sjögren´s syndrome: symptoms, pulmonary function tests and HRCT
Source: Eur Respir J 2004; 24: Suppl. 48, 487s
Year: 2004

Pulmonary function trends predict mortality in patients with hypersensitivity pneumonitis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Source: Eur Respir J 2006; 27: 143-150
Year: 2006



Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015

The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire
Source: International Congress 2014 – COPD markers
Year: 2014


Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019



Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J 2009; 33: 68-76
Year: 2009



Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Microbiological follow-up of patients with non-CF bronchiectasis related to exacerbation frequency, pulmonary function tests (PFT) and HRCT-score
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003



Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP)
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020


Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


The relationship between the clinical symptoms, BALF cells and indices of respiratory function in patients with newly diagnosed sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 534s
Year: 2004